Study S001105

A Prospective, Non-interventional, Single Arm Study Investigating Long-term Glycaemic Control in Patients With Type 2 Diabetes Initiating Xultophy® (IDegLira) in a Realworld Setting in Italy

ClinicalTrials.gov record

Registration

Registration: NCT04666987
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 359
Start: 2020-10-21
Primary completion: 2022-12-30
Lead sponsor: Novo Nordisk A/S
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:Insulin degludec and liraglutide (IDegLira)
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1253-1809

Registered primary outcomes

Change in Glycated Haemoglobin (HbA1c) [From baseline (V0, month 0) to 6 months after initiation.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.